Disease/Infection News

RSS

Portable SERS test detects harmful bacteria in beef within minutes

A breakthrough method combines silver nanoparticles and Raman spectroscopy for quick detection of foodborne pathogens in beef, improving safety standards.

10 Oct 2025

New insights into malaria proteins offer pathway to blocking parasite transmission

Using millions of microscope images magnified up to 130,000 times, researchers from Radboud university medical center and Toronto have unraveled the structure of two key proteins in the malaria parasite.

10 Oct 2025

First global standard published to measure outcomes in dengue treatment trials

The first global standard which harmonizes what outcomes to measure in dengue treatment trials has been published this week in The Lancet Infectious Diseases. Co-led by researchers at King's and the University of Oxford, this solves a longstanding discrepancy in terms of what is measured in these trials.

9 Oct 2025

Study reveals how RfaH protein acts as a protective shield for bacterial genes

Researchers at Umeå University have identified a key molecular player that helps bacteria survive the hostile environment inside the body.

9 Oct 2025

Study reveals large differences in knowledge about ticks between countries

Ticks are found all over the world. There are more than 900 species, and many of them pass on dangerous diseases to both humans and animals.

9 Oct 2025

Obesity-linked fat vesicles accelerate amyloid aggregation in Alzheimer’s disease

Researchers discuss the role of extracellular vesicles as a potential link between obesity and Alzheimer’s disease.

9 Oct 2025

Brainstem damage found to be behind long-lasting effects of severe Covid-19

Damage to the brainstem - the brain's 'control center' - is behind long-lasting physical and psychiatric effects of severe Covid-19 infection, a study suggests.

8 Oct 2025

New dual-target vaccine shows promise against typhoid and Salmonella

Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.

8 Oct 2025

Taste-based flu test that detects infection within minutes

Researchers examine the effectiveness of a novel taste-based sensor for the early detection of influenza infection.

8 Oct 2025

$4 million grant supports effort to turn enzyme-targeting science into treatments for Cryptosporidium infections

A University of Houston professor has received nearly $4 million in new support from the National Institute of Allergy and Infectious Diseases to lead a translational effort turning enzyme-targeting science into urgently needed treatments for Cryptosporidium infections – which are caused by a life-threatening pathogen and have no existing cure.

7 Oct 2025

Discovery opens up new avenues for treating rotavirus infections

Rotavirus causes severe dehydrating diarrhea in infants and young children, contributing to more than 128,500 deaths per year globally despite widespread vaccination efforts.

7 Oct 2025

Tanzania turns to mass dog vaccination and smarter surveillance against rabies spread

Salama Issa watched in helpless shock as her seven-year-old son was set upon by a stray dog in Mmongo village, in the Lindi region of Tanzania.

7 Oct 2025

PAHO introduces new tool to accelerate disease elimination in the Americas

During a briefing session at the 62nd Directing Council of the Pan American Health Organization (PAHO), officials presented a new technical tool to help countries in the Region of the Americas accelerate the elimination of more than 30 communicable diseases and related conditions.

6 Oct 2025

Researchers discover how HIV hides in different parts of the body

Researchers at Western University and the University of Calgary have discovered how HIV hides in different parts of the body by embedding itself into the DNA of cells in a tissue-specific manner, offering new insights into why the virus is so difficult to eliminate and cure – even decades after infection and treatment.

6 Oct 2025

Breakthrough in RNA-targeted drug discovery offers hope against viral diseases

In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus that causes COVID-19.

6 Oct 2025

Common food additives may trigger childhood asthma

Researchers utilize metabolomics to investigate the mechanisms underlying the association between food additives and childhood asthma.

6 Oct 2025

Azelastine nasal spray prevents COVID-19 and rhinovirus infections

Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.

6 Oct 2025

Antihypertensive and lipid-lowering drugs show efficacy against steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one third of the adult population. This disorder is characterized by the accumulation of fat in liver cells, which has severe liver consequences and is also associated with a high mortality rate from cardiovascular disease.

6 Oct 2025

New research reveals the cervix as a truly immunocompetent tissue

Cervical epithelial cells are far from passive bystanders in the body's immune system. New research shows they actually play an active and highly coordinated role in detecting and fighting infections. That's the conclusion of an international research team led by Associate Professor Cindrilla Chumduri from Aarhus University, and now published in the journal Science Advances.

6 Oct 2025

Large-scale analysis offers insights into sporadic nature of chikungunya virus outbreaks

The symptoms come on quickly - acute fever, followed by debilitating joint pain that can last for months. Though rarely fatal, the chikungunya virus, a mosquito-borne illness, can be particularly severe for high-risk individuals, including newborns and older adults.

6 Oct 2025